Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.355
-0.055 (-3.90%)
At close: May 11, 2026, 4:00 PM EDT
1.350
-0.005 (-0.37%)
Pre-market: May 12, 2026, 6:13 AM EDT

PACB Revenue

Pacific Biosciences of California had revenue of $37.18M in the quarter ending March 31, 2026, with 0.07% growth. This brings the company's revenue in the last twelve months to $160.03M, up 5.04% year-over-year. In the year 2025, Pacific Biosciences of California had annual revenue of $160.01M with 3.89% growth.

Revenue (ttm)
$160.03M
Revenue Growth
+5.04%
P/S Ratio
2.63
Revenue / Employee
$329,959
Employees
485
Market Cap
420.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025160.01M5.99M3.89%
Dec 31, 2024154.01M-46.51M-23.19%
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 202078.89M-12.00M-13.20%
Dec 31, 201990.89M12.27M15.60%
Dec 31, 201878.63M-14.84M-15.88%
Dec 31, 201793.47M2.75M3.04%
Dec 31, 201690.71M-2.07M-2.23%
Dec 31, 201592.78M32.19M53.12%
Dec 31, 201460.59M32.41M115.02%
Dec 31, 201328.18M2.20M8.46%
Dec 31, 201225.98M-7.88M-23.27%
Dec 31, 201133.86M32.19M1,922.88%
Dec 31, 20101.67M1.54M1,140.00%
Dec 31, 2009135.00K-766.00K-85.02%
Dec 31, 2008901.00K-1.26M-58.34%
Dec 31, 20072.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Varex Imaging857.50M
Orthofix Medical825.37M
OrthoPediatrics243.30M
Cerus216.56M
SI-BONE200.93M
Beta Bionics110.24M
Delcath Systems90.44M
Standard BioTools86.26M
Revenue Rankings